Search For "covid 19 vaccine candidate"
Premas Biotech reports positive preliminary Phase-1 data for its oral Covi
Updated : 3 years, 7 months ago IST
Gurugram (Haryana) [India], October 8 (ANI/PRNewswire): Premas Biotech, developer of technologies & bioprocesses for novel proteins, today announced that Oravax Medical Inc., a US-based company that Premas Biotech is a shareholder in, reported positive preliminary data from its Phase 1 t
Read More
Covaxin to be evaluated as COVID-19 vaccine candidate in US: Bharat Biotec
Updated : 4 years, 3 months ago IST
Hyderabad (Telangana) [India], February 19 (ANI): Hyderabad-based Bharat Biotech on Saturday said its COVID-19 vaccine Covaxin will be evaluated as a vaccine candidate for the disease in the United States.
Read More
Novavax, Serum Institute file for emergency use authorisation of Novavax'
Updated : 4 years, 4 months ago IST
Gaithersburg [US], January 10 (ANI): Novavax, a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India (SII), on Monday, announced a regulatory submission to the South African Health Products Re
Read More
Covaxin found to be safe, immunogenic in 2-18 age group in phase 2, 3 stud
Updated : 4 years, 4 months ago IST
Hyderabad (Telangana) [India], December 30 (ANI): Hyderabad based vaccine manufacturer Bharat Biotech on Thursday announced that Covaxin (BBV152) has been found to be "safe, well-tolerated, and immunogenic" in the age group of 2-18 years in phase II/III study, said a company's statement.
Read More
Oravax and Genomma Lab announce JV to commercialize oral COVID-19 vaccine
Updated : 4 years, 6 months ago IST
Gurugram (Haryana) [India], November 20 (ANI/BusinessWire India): Premas Biotech together with their partners Oramed Pharmaceuticals Inc. (Nasdaq/TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, and Genomma Lab In
Read More
SEC recommends Phase 1 clinical trials of Reliance's Covid Vaccine candida
Updated : 4 years, 9 months ago IST
New Delhi [India], August 27 (ANI): The Subject Expert Committee (SEC) has recommended Phase 1 clinical trials of Reliance's recombinant COVID-19 vaccine candidate.
Read More
Sanofi, GSK receive approval for Phase 3 trial of COVID vaccine in India
Updated : 4 years, 10 months ago IST
New Delhi [India], July 8 (ANI): French pharmaceutical company Sanofi and its British partner GSK (GlaxoSmithKline plc) received approval for their Phase 3 clinical study in India, to assess the safety, efficacy and immunogenicity of their adjuvanted recombinant-protein COVID-19 vaccine cand
Read More
Seven COVID-19 vaccine candidates in clinical trials, says Harsh Vardhan
Updated : 5 years, 1 month ago IST
New Delhi [India], March 30 (ANI): Union Health Minister Harsh Vardhan on Tuesday said that seven more COVID-19 vaccine candidates are in stages of clinical trials.
Read More
Independent US board expresses concern over AstraZeneca's announcements ab
Updated : 5 years, 2 months ago IST
Washington [US], March 23 (ANI): An independent board that reviews data from multiple Covid-19 vaccine candidates in the United States has expressed concern over AstraZeneca's announcements about its latest findings, according to a statement posted Tuesday by the National Institute of Allerg
Read More
Sanofi, GSK start phase 2 trial of their COVID-19 vaccine, phase 3 could b
Updated : 5 years, 3 months ago IST
Paris [France], February 22 (ANI): Sanofi and GlaxoSmithKline (GSK) said on Monday they had begun a phase 2 trial of their COVID-19 vaccine candidates, and if results are positive, a phase 3 study could start in the second quarter of 2021.
Read More
UK buys another 40 million doses of French COVID-19 vaccine Valneva
Updated : 5 years, 3 months ago IST
London [UK], February 1 (ANI/Sputnik): The United Kingdom secured on Monday 40 million extra doses of the Valneva COVID-19 vaccine candidate, taking to 100 million the total number of doses it has purchased from the French biotech company, the UK government announced.
Read More
COVID-19: Bharat Biotech recruits 23,000 volunteers for COVAXIN's phase 3
Updated : 5 years, 4 months ago IST
Hyderabad (Telangana) [India], January 2 (ANI): Bharat Biotech has recruited 23,000 volunteers so far for the Phase III clinical trials of its COVID-19 vaccine candidate, 'COVAXIN'.
Read More